The goal of this work is to produce well-characterized, high titer, infectious transmitted/founder HIV-1 viruses. Viruses of different clades will be produced, and all will be fluorescently labelled. The viruses will be distributed to Program members for evaluation of antibody function.
|Effective start/end date||5/1/16 → 4/30/21|
- Duke University (2035489//5P01AI120756-03)
- National Institute of Allergy and Infectious Diseases (2035489//5P01AI120756-03)